首页 > 最新文献

Ocular Oncology and Pathology最新文献

英文 中文
Front & Back Matter 正面和背面
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 DOI: 10.1159/000520013
{"title":"Front & Back Matter","authors":"","doi":"10.1159/000520013","DOIUrl":"https://doi.org/10.1159/000520013","url":null,"abstract":"","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"55 1","pages":""},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87161862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uveal Melanoma: Refusal of Treatment. 葡萄膜黑色素瘤:拒绝治疗。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-08-27 DOI: 10.1159/000515559
Randy Christopher Bowen, Soto Hansell, Vishal Raval, Jacquelyn M Davanzo, Arun D Singh

Purpose: This study aimed to explore factors for refusing treatment in patients diagnosed with uveal melanoma and their subsequent clinical course.

Methods: This study included patients with uveal melanoma who refused standard of care treatment. Patient-reported reasons and pre-existing mental health diagnoses were assessed. The sociodemographic profile was compared with the controls. Ocular survival, metastasis-free survival (MFS), and overall survival (OS) were calculated.

Results: Nine patients with uveal melanoma declined ocular treatment (plaque brachytherapy, n = 7 [78%]; enucleation, n = 2 [22%]). The choroidal melanomas were small (n = 1 [11%]), medium (n = 5 [56%]), and large (n = 3 [33%]) in size (COMS criteria). The sociodemographic profile of the study patients was not different from those that accepted treatment. One patient (11%) had pre-existing mental health diagnosis. Five patients (56%) eventually accepted treatment following an average delay of 19 months (range: 4-55 months) due to neovascular glaucoma or severe vision loss. MFS could not be ascertained, and OS was 67% (6/9) at 4.2 years of follow-up (mean).

Conclusions: Refusal of initial recommended treatment is associated with poor ocular survival. The small sample size did not allow for an evaluation of the impact on survival.

目的:本研究旨在探讨葡萄膜黑色素瘤患者拒绝治疗的因素及其随后的临床病程。方法:本研究纳入了拒绝标准护理治疗的葡萄膜黑色素瘤患者。评估了患者报告的原因和先前的心理健康诊断。将社会人口统计资料与对照组进行比较。计算眼部生存、无转移生存(MFS)和总生存(OS)。结果:9例葡萄膜黑色素瘤患者眼部治疗下降(斑块近距离治疗,n = 7 [78%];去核,n = 2[22%])。脉络膜黑色素瘤按COMS标准分为小(n = 1[11%])、中(n = 5[56%])和大(n = 3[33%])。研究患者的社会人口学特征与接受治疗的患者并无不同。一名患者(11%)先前有精神健康诊断。由于新生血管性青光眼或严重视力丧失,5名患者(56%)在平均延迟19个月(范围:4-55个月)后最终接受了治疗。MFS无法确定,平均随访4.2年,OS为67%(6/9)。结论:拒绝最初推荐的治疗与眼部生存不良有关。样本量小,无法评估对生存的影响。
{"title":"Uveal Melanoma: Refusal of Treatment.","authors":"Randy Christopher Bowen,&nbsp;Soto Hansell,&nbsp;Vishal Raval,&nbsp;Jacquelyn M Davanzo,&nbsp;Arun D Singh","doi":"10.1159/000515559","DOIUrl":"https://doi.org/10.1159/000515559","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to explore factors for refusing treatment in patients diagnosed with uveal melanoma and their subsequent clinical course.</p><p><strong>Methods: </strong>This study included patients with uveal melanoma who refused standard of care treatment. Patient-reported reasons and pre-existing mental health diagnoses were assessed. The sociodemographic profile was compared with the controls. Ocular survival, metastasis-free survival (MFS), and overall survival (OS) were calculated.</p><p><strong>Results: </strong>Nine patients with uveal melanoma declined ocular treatment (plaque brachytherapy, <i>n</i> = 7 [78%]; enucleation, <i>n</i> = 2 [22%]). The choroidal melanomas were small (<i>n</i> = 1 [11%]), medium (<i>n</i> = 5 [56%]), and large (<i>n</i> = 3 [33%]) in size (COMS criteria). The sociodemographic profile of the study patients was not different from those that accepted treatment. One patient (11%) had pre-existing mental health diagnosis. Five patients (56%) eventually accepted treatment following an average delay of 19 months (range: 4-55 months) due to neovascular glaucoma or severe vision loss. MFS could not be ascertained, and OS was 67% (6/9) at 4.2 years of follow-up (mean).</p><p><strong>Conclusions: </strong>Refusal of initial recommended treatment is associated with poor ocular survival. The small sample size did not allow for an evaluation of the impact on survival.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"361-367"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531830/pdf/oop-0007-0361.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39580067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Germ Line BAP1 Mutation in Patients with Uveal Melanoma and Renal Cell Carcinoma. 葡萄膜黑色素瘤和肾细胞癌患者生殖系BAP1突变
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-06-30 DOI: 10.1159/000516695
Yusra F Shao, Meghan DeBenedictis, Gabrielle Yeaney, Arun D Singh

Uveal melanoma (UM) and renal cell carcinoma (RCC) can occur sporadically and as a manifestation of BAP1 tumor predisposition syndrome. We aimed to understand the prevalence of germ line BAP1 pathogenic variants in patients with UM and RCC. We reviewed patients managed at Cleveland Clinic between November 2003 and November 2019 who were diagnosed with UM and RCC. Charts were reviewed for demographic and cancer-related characteristics. RCC samples were tested for BAP1 protein expression using immunohistochemical (IHC) staining, and testing for germ line BAP1 pathogenic variants was performed as part of routine clinical care. Thirteen patients were included in the study. The average age at diagnosis of UM was 61.3 years. Seven patients underwent fine-needle aspiration biopsy for prognostic testing of UM (low risk =5, high risk =2). Twelve patients were treated with plaque radiation therapy, and 3 patients developed metastatic disease requiring systemic therapy. The median time to diagnosis of RCC from time of diagnosis of UM was 0 months. RCC samples were available for 7 patients for BAP1 IHC staining (intact =6, loss =1). All patients underwent nephrectomy (total = 3, partial = 8, unknown =2), and 1 received systemic therapy for metastatic RCC. Six patients underwent germ line BAP1 genetic testing. Of these, 1 patient was heterozygous for a pathogenic variant of BAP1 gene: c.1781-1782delGG, p.Gly594Valfs*48. The overall prevalence of germ line BAP1 pathogenic variants in our study was high (1/6; 17%; 95% CI 0-46%). Patients with UM and RCC should be referred for genetic counseling to discuss genetic testing.

葡萄膜黑色素瘤(UM)和肾细胞癌(RCC)可以零星发生,是BAP1肿瘤易感综合征的一种表现。我们的目的是了解生殖系BAP1致病变异在UM和RCC患者中的患病率。我们回顾了2003年11月至2019年11月期间在克利夫兰诊所被诊断为UM和RCC的患者。对图表进行了人口统计学和癌症相关特征的审查。使用免疫组织化学(IHC)染色检测RCC样本BAP1蛋白表达,并作为常规临床护理的一部分检测生殖系BAP1致病变异。13名患者参与了这项研究。诊断UM的平均年龄为61.3岁。7例患者接受细针穿刺活检以检测UM的预后(低风险=5,高风险=2)。12例患者接受斑块放射治疗,3例患者发生转移性疾病,需要全身治疗。从UM诊断到RCC诊断的中位时间为0个月。7例患者的RCC样本可用于BAP1 IHC染色(完整=6,丢失=1)。所有患者均行肾切除术(总3例,部分8例,未知2例),1例接受转移性肾细胞癌的全身治疗。6例患者进行了种系BAP1基因检测。其中1例患者BAP1基因致病性变异为杂合子:c.1781-1782delGG, p.Gly594Valfs*48。在我们的研究中,种系BAP1致病变异的总体患病率很高(1/6;17%;95% ci 0-46%)。患有UM和RCC的患者应进行遗传咨询以讨论基因检测。
{"title":"Germ Line <i>BAP1</i> Mutation in Patients with Uveal Melanoma and Renal Cell Carcinoma.","authors":"Yusra F Shao,&nbsp;Meghan DeBenedictis,&nbsp;Gabrielle Yeaney,&nbsp;Arun D Singh","doi":"10.1159/000516695","DOIUrl":"https://doi.org/10.1159/000516695","url":null,"abstract":"<p><p>Uveal melanoma (UM) and renal cell carcinoma (RCC) can occur sporadically and as a manifestation of <i>BAP1</i> tumor predisposition syndrome. We aimed to understand the prevalence of germ line <i>BAP1</i> pathogenic variants in patients with UM and RCC. We reviewed patients managed at Cleveland Clinic between November 2003 and November 2019 who were diagnosed with UM and RCC. Charts were reviewed for demographic and cancer-related characteristics. RCC samples were tested for <i>BAP1</i> protein expression using immunohistochemical (IHC) staining, and testing for germ line <i>BAP1</i> pathogenic variants was performed as part of routine clinical care. Thirteen patients were included in the study. The average age at diagnosis of UM was 61.3 years. Seven patients underwent fine-needle aspiration biopsy for prognostic testing of UM (low risk =5, high risk =2). Twelve patients were treated with plaque radiation therapy, and 3 patients developed metastatic disease requiring systemic therapy. The median time to diagnosis of RCC from time of diagnosis of UM was 0 months. RCC samples were available for 7 patients for BAP1 IHC staining (intact =6, loss =1). All patients underwent nephrectomy (total = 3, partial = 8, unknown =2), and 1 received systemic therapy for metastatic RCC. Six patients underwent germ line <i>BAP1</i> genetic testing. Of these, 1 patient was heterozygous for a pathogenic variant of <i>BAP1</i> gene: c.1781-1782delGG, p.Gly594Valfs*48. The overall prevalence of germ line <i>BAP1</i> pathogenic variants in our study was high (1/6; 17%; 95% CI 0-46%). Patients with UM and RCC should be referred for genetic counseling to discuss genetic testing.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"340-345"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000516695","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39580064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Vitrectomy-Assisted Biopsy: An in vitro Study on the Impact of Cut Rate and Probe Size. 玻璃体切除术辅助活检:切割率和探针大小影响的体外研究。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-07-08 DOI: 10.1159/000516960
Erlend Ulltang, Jens Folke Kiilgaard, Nazanin Mola, David Scheie, Steffen Heegaard, Jørgen Krohn

Purpose: The aim of this study was to optimize the technique of performing vitrectomy-assisted biopsy of intraocular tumors by comparing the cytohistological findings in specimens obtained with different vitrectomy probes and cut rates.

Methods: Vitrectomy-assisted biopsies were taken from a fresh porcine liver. For each sampling, the vacuum level was 300 mm Hg. The following parameters were compared; cut rate (60, 600 and 6,000 cuts per minute [cpm]), probe type (standard and two-dimensional cutting [TDC]), and probe diameter (23-gauge and 25-gauge). The specimens were assessed by automated whole-slide imaging analysis and conventional light microscopy.

Results: Seventy-two biopsies were analyzed for the number of hepatocytes, total area of tissue fragments, and total stained area of each microscope slide. For all probe types, these parameters were significantly and positively correlated with the cut rate. TDC probes led to significantly higher scores than those of standard probes, independent of the cut rate. There were no significant differences in results when using 23-gauge or 25-gauge standard probes. Light microscopic examination demonstrated well-preserved cells sufficient for cytohistological analyses in all investigated cases.

Conclusions: The higher the cut rate, the larger is the amount of aspirated cellular material. There were no significant differences between 23-gauge and 25-gauge biopsies. Cut rates up to 6,000 cpm did not adversely affect the cytohistological features of the samples.

目的:本研究的目的是通过比较不同玻璃体切除术探针和切割率获得的标本的细胞组织学结果,优化玻璃体切除术辅助眼内肿瘤活检的技术。方法:采用玻璃体切除辅助活组织检查,取新鲜猪肝。每次取样,真空度为300 mm Hg。比较以下参数:切割速度(每分钟60、600和6000次切割[cpm])、探头类型(标准和二维切割[TDC])和探头直径(23规和25规)。采用全自动全玻片成像分析和常规光学显微镜对标本进行评估。结果:分析72例活组织切片的肝细胞数量、组织碎片总面积和每张载玻片的总染色面积。对于所有探头类型,这些参数与切割率显著正相关。与切割率无关,TDC探针的得分明显高于标准探针。在使用23号和25号标准探针时,结果没有显著差异。光镜检查显示保存完好的细胞足以用于所有调查病例的细胞组织学分析。结论:切割率越高,吸出的细胞物质越多。23号和25号活检无显著差异。高达6,000 cpm的切割率对样品的细胞组织学特征没有不利影响。
{"title":"Vitrectomy-Assisted Biopsy: An in vitro Study on the Impact of Cut Rate and Probe Size.","authors":"Erlend Ulltang,&nbsp;Jens Folke Kiilgaard,&nbsp;Nazanin Mola,&nbsp;David Scheie,&nbsp;Steffen Heegaard,&nbsp;Jørgen Krohn","doi":"10.1159/000516960","DOIUrl":"https://doi.org/10.1159/000516960","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to optimize the technique of performing vitrectomy-assisted biopsy of intraocular tumors by comparing the cytohistological findings in specimens obtained with different vitrectomy probes and cut rates.</p><p><strong>Methods: </strong>Vitrectomy-assisted biopsies were taken from a fresh porcine liver. For each sampling, the vacuum level was 300 mm Hg. The following parameters were compared; cut rate (60, 600 and 6,000 cuts per minute [cpm]), probe type (standard and two-dimensional cutting [TDC]), and probe diameter (23-gauge and 25-gauge). The specimens were assessed by automated whole-slide imaging analysis and conventional light microscopy.</p><p><strong>Results: </strong>Seventy-two biopsies were analyzed for the number of hepatocytes, total area of tissue fragments, and total stained area of each microscope slide. For all probe types, these parameters were significantly and positively correlated with the cut rate. TDC probes led to significantly higher scores than those of standard probes, independent of the cut rate. There were no significant differences in results when using 23-gauge or 25-gauge standard probes. Light microscopic examination demonstrated well-preserved cells sufficient for cytohistological analyses in all investigated cases.</p><p><strong>Conclusions: </strong>The higher the cut rate, the larger is the amount of aspirated cellular material. There were no significant differences between 23-gauge and 25-gauge biopsies. Cut rates up to 6,000 cpm did not adversely affect the cytohistological features of the samples.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"346-352"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000516960","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39580065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrence of Primary Breast Lymphoma Presenting as Bilateral Vitreoretinal Lymphoma. 原发性乳腺淋巴瘤复发表现为双侧玻璃体视网膜淋巴瘤。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-05-19 DOI: 10.1159/000515560
Karishma Habbu, Roshan George, Miguel Materin

Purpose: This report describes a case of relapsed primary breast lymphoma (PBL) presenting as vitreoretinal lymphoma (VRL).

Methods: We describe the clinical and hematopathologic findings in a patient with relapsed PBL involving the vitreous of both eyes.

Results: A 59-year-old woman was treated for PBL with systemic and intrathecal chemotherapy 5 years prior to presentation. Three years later, she presented to an outside clinic with blurred vision in both eyes and bilateral vitritis. She was referred to our clinic with concern for ocular lymphoma. On presentation, the patient's best-corrected visual acuity was 20/40 in the right eye and 20/25 in the left eye with 3+ vitreous cells in the right eye and 2+ vitreous cells in the left eye. Vitreous biopsy of the right eye revealed CD5-negative/CD10-negative B-cell lymphoma cells on flow cytometry. She had no evidence of disease on brain MRI, lumbar puncture, bone marrow biopsy, or full-body CT scans. She was treated with a regimen of rituximab, methotrexate, procarbazine, and vincristine for central nervous system penetration as well as multiple intraocular injections of methotrexate and rituximab with improvement in vision and ocular inflammation bilaterally.

Conclusion: Relapsed PBL can present as bilateral VRL.

目的:本报告报告一例复发性原发性乳腺淋巴瘤(PBL),表现为玻璃体视网膜淋巴瘤(VRL)。方法:我们描述了一个复发性PBL累及双眼玻璃体的患者的临床和血液病理学表现。结果:一名59岁的女性在发病前5年接受了全身和鞘内化疗。三年后,她以双眼视力模糊和双侧玻璃体炎就诊于门诊。她因眼部淋巴瘤被转介到我们诊所。患者就诊时,最佳矫正视力为右眼20/40,左眼20/25,右眼3+玻璃体细胞,左眼2+玻璃体细胞。右眼玻璃体活检显示cd5阴性/ cd10阴性b细胞淋巴瘤细胞。颅脑MRI、腰椎穿刺、骨髓活检或全身CT扫描均未发现病变。患者接受利妥昔单抗、甲氨蝶呤、丙卡嗪和新碱治疗,用于穿透中枢神经系统,并多次眼内注射甲氨蝶呤和利妥昔单抗,双侧视力和眼部炎症均有改善。结论:复发性PBL可表现为双侧VRL。
{"title":"Recurrence of Primary Breast Lymphoma Presenting as Bilateral Vitreoretinal Lymphoma.","authors":"Karishma Habbu,&nbsp;Roshan George,&nbsp;Miguel Materin","doi":"10.1159/000515560","DOIUrl":"https://doi.org/10.1159/000515560","url":null,"abstract":"<p><strong>Purpose: </strong>This report describes a case of relapsed primary breast lymphoma (PBL) presenting as vitreoretinal lymphoma (VRL).</p><p><strong>Methods: </strong>We describe the clinical and hematopathologic findings in a patient with relapsed PBL involving the vitreous of both eyes.</p><p><strong>Results: </strong>A 59-year-old woman was treated for PBL with systemic and intrathecal chemotherapy 5 years prior to presentation. Three years later, she presented to an outside clinic with blurred vision in both eyes and bilateral vitritis. She was referred to our clinic with concern for ocular lymphoma. On presentation, the patient's best-corrected visual acuity was 20/40 in the right eye and 20/25 in the left eye with 3+ vitreous cells in the right eye and 2+ vitreous cells in the left eye. Vitreous biopsy of the right eye revealed CD5-negative/CD10-negative B-cell lymphoma cells on flow cytometry. She had no evidence of disease on brain MRI, lumbar puncture, bone marrow biopsy, or full-body CT scans. She was treated with a regimen of rituximab, methotrexate, procarbazine, and vincristine for central nervous system penetration as well as multiple intraocular injections of methotrexate and rituximab with improvement in vision and ocular inflammation bilaterally.</p><p><strong>Conclusion: </strong>Relapsed PBL can present as bilateral VRL.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"311-315"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000515560","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39684538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripapillary Neuroendocrine Carcinoma Metastasis: A Novel Approach to Treatment. 乳头周围神经内分泌癌转移:一种新的治疗方法。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-06-02 DOI: 10.1159/000510276
Colin S Ip, Yuval Raizen, David Goldfarb, Eric Kegley, Jose Munoz, Amy C Schefler

Peripapillary and circumpapillary retinal intraocular metastases are rare and present a treatment challenge for ophthalmologists because of the high risk of iatrogenic injury to the optic nerve. There are no clear guidelines on the management of these lesions, and many clinicians will initially observe for improvement of the metastases with systemic chemotherapy before considering local therapy with external beam radiation. Radiation to the optic disc carries a significant risk of injuring the optic nerve, leading to worsening of vision. Alternative treatment approaches are needed. We present a patient with large-cell neuroendocrine carcinoma with metastasis to the peripapillary retina who was treated with intravitreal topotecan and with intravitreal aflibercept. Serial fundus photos, ultrasound, and optical coherence tomography demonstrated a reduction in size of the lesion and a decrease in subretinal fluid with intravitreal topotecan and aflibercept. In addition, visual acuity was stabilized during treatment. Intravitreal chemotherapy for intraocular metastases in vision-sensitive areas such as the peripapillary retina may be a viable alternative for patients who seek to preserve their vision and maintain their quality of life.

乳头周围和乳头周围视网膜眼内转移是罕见的,并且由于视神经医源性损伤的高风险,对眼科医生来说是一个治疗挑战。对于这些病变的处理尚无明确的指导方针,许多临床医生会先观察全身化疗对转移的改善,然后再考虑局部治疗外束放疗。视盘放射有损伤视神经的危险,导致视力恶化。需要其他治疗方法。我们报告了一位有转移到乳头周围视网膜的大细胞神经内分泌癌患者,他接受了玻璃体腔内拓扑替康和玻璃体腔内阿伯西普的治疗。连续眼底照片、超声和光学相干断层扫描显示,玻璃体内注射拓扑替康和阿伯西普后,病变大小减小,视网膜下液体减少。治疗期间视力稳定。对于视力敏感区域(如乳头周围视网膜)的眼内转移瘤,玻璃体内化疗可能是寻求保留视力和维持生活质量的患者的可行选择。
{"title":"Peripapillary Neuroendocrine Carcinoma Metastasis: A Novel Approach to Treatment.","authors":"Colin S Ip,&nbsp;Yuval Raizen,&nbsp;David Goldfarb,&nbsp;Eric Kegley,&nbsp;Jose Munoz,&nbsp;Amy C Schefler","doi":"10.1159/000510276","DOIUrl":"https://doi.org/10.1159/000510276","url":null,"abstract":"<p><p>Peripapillary and circumpapillary retinal intraocular metastases are rare and present a treatment challenge for ophthalmologists because of the high risk of iatrogenic injury to the optic nerve. There are no clear guidelines on the management of these lesions, and many clinicians will initially observe for improvement of the metastases with systemic chemotherapy before considering local therapy with external beam radiation. Radiation to the optic disc carries a significant risk of injuring the optic nerve, leading to worsening of vision. Alternative treatment approaches are needed. We present a patient with large-cell neuroendocrine carcinoma with metastasis to the peripapillary retina who was treated with intravitreal topotecan and with intravitreal aflibercept. Serial fundus photos, ultrasound, and optical coherence tomography demonstrated a reduction in size of the lesion and a decrease in subretinal fluid with intravitreal topotecan and aflibercept. In addition, visual acuity was stabilized during treatment. Intravitreal chemotherapy for intraocular metastases in vision-sensitive areas such as the peripapillary retina may be a viable alternative for patients who seek to preserve their vision and maintain their quality of life.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"316-320"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000510276","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39684539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors. 光学相干断层扫描血管造影在视网膜母细胞瘤治疗前后的微血管变化。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-06-02 DOI: 10.1159/000515142
Juan P Fernandez, Asghar A Haider, Lejla Vajzovic, Arathi Ponugoti, Michael P Kelly, Miguel A Materin

Introduction: The purpose of this study is to describe variations in microvasculature before and after treatment of treatment-naive lesions and during consolidation therapy of retinoblastoma lesions using an investigational portable optical coherence tomography angiography (OCTA) system.

Methods: This study is a single-center, prospective, observational case series. Recruited subjects were either undergoing surveillance for retinoblastoma or had newly detected retinoblastoma. Nine tumors from 7 eyes in 6 patients were included. During exams under anesthesia, the tumors were imaged with an investigational portable OCTA system. OCTA images were analyzed to assess vascular changes before and after treatment.

Results: In all 6 presented cases, OCTA imaging revealed distinctive vascular patterns, such as dilated feeder arteries and draining veins, disorganized and complex branching patterns, irregular vessel calibers, and dilation and tortuosity of vessels. After treatment, OCTA imaging revealed decreased intrinsic tumor vascularity and reduced dilation of draining and feeder vessels. Tumor relapse demonstrated prominent vascularity (n = 1) that resolved on repeat OCTA after transpupillary thermotherapy treatment. Type 2 (n = 1), 3 (n = 6), and 4 (n = 1) tumor regression patterns were seen in our patients after treatment, and OCTA findings were consistent with a previously published report. Interestingly, in one of the presented cases, OCTA demonstrated clear feeder, draining, and intrinsic tumor vessels that were not as evident on fluorescein angiography.

Conclusions: OCTA may offer a noninvasive and sensitive technique to evaluate the vasculature of both the tumor and the surrounding retina in retinoblastoma. With additional research and development into its use in patients with retinoblastoma, OCTA may one day be useful in assessing treatment response and residual tumor activity.

本研究的目的是利用便携式光学相干断层扫描血管造影(OCTA)系统描述视网膜母细胞瘤病变治疗前后和巩固治疗期间微血管系统的变化。方法:本研究采用单中心、前瞻性、观察性病例系列。招募的受试者要么正在接受视网膜母细胞瘤的监测,要么是新发现的视网膜母细胞瘤。包括6例患者7只眼的9个肿瘤。在麻醉下检查时,使用便携式OCTA系统对肿瘤进行成像。分析OCTA图像以评估治疗前后血管的变化。结果:所有6例病例,OCTA成像均显示明显的血管模式,如供血动脉和引流静脉扩张,分支模式紊乱和复杂,血管直径不规则,血管扩张和扭曲。治疗后,OCTA成像显示肿瘤固有血管减少,引流血管和供血血管扩张减少。肿瘤复发表现为明显的血管增生(n = 1),经经上突热疗治疗后再次行OCTA治疗。我们的患者在治疗后观察到2型(n = 1)、3型(n = 6)和4型(n = 1)肿瘤消退模式,OCTA结果与先前发表的报告一致。有趣的是,在其中一个病例中,OCTA显示了清晰的喂食、引流和固有的肿瘤血管,而荧光素血管造影并不明显。结论:OCTA可以提供一种无创、灵敏的技术来评估视网膜母细胞瘤的肿瘤和周围视网膜的血管系统。随着对其在视网膜母细胞瘤患者中的应用的进一步研究和开发,OCTA可能有一天会用于评估治疗反应和残余肿瘤活性。
{"title":"Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors.","authors":"Juan P Fernandez,&nbsp;Asghar A Haider,&nbsp;Lejla Vajzovic,&nbsp;Arathi Ponugoti,&nbsp;Michael P Kelly,&nbsp;Miguel A Materin","doi":"10.1159/000515142","DOIUrl":"https://doi.org/10.1159/000515142","url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this study is to describe variations in microvasculature before and after treatment of treatment-naive lesions and during consolidation therapy of retinoblastoma lesions using an investigational portable optical coherence tomography angiography (OCTA) system.</p><p><strong>Methods: </strong>This study is a single-center, prospective, observational case series. Recruited subjects were either undergoing surveillance for retinoblastoma or had newly detected retinoblastoma. Nine tumors from 7 eyes in 6 patients were included. During exams under anesthesia, the tumors were imaged with an investigational portable OCTA system. OCTA images were analyzed to assess vascular changes before and after treatment.</p><p><strong>Results: </strong>In all 6 presented cases, OCTA imaging revealed distinctive vascular patterns, such as dilated feeder arteries and draining veins, disorganized and complex branching patterns, irregular vessel calibers, and dilation and tortuosity of vessels. After treatment, OCTA imaging revealed decreased intrinsic tumor vascularity and reduced dilation of draining and feeder vessels. Tumor relapse demonstrated prominent vascularity (<i>n</i> = 1) that resolved on repeat OCTA after transpupillary thermotherapy treatment. Type 2 (<i>n</i> = 1), 3 (<i>n</i> = 6), and 4 (<i>n</i> = 1) tumor regression patterns were seen in our patients after treatment, and OCTA findings were consistent with a previously published report. Interestingly, in one of the presented cases, OCTA demonstrated clear feeder, draining, and intrinsic tumor vessels that were not as evident on fluorescein angiography.</p><p><strong>Conclusions: </strong>OCTA may offer a noninvasive and sensitive technique to evaluate the vasculature of both the tumor and the surrounding retina in retinoblastoma. With additional research and development into its use in patients with retinoblastoma, OCTA may one day be useful in assessing treatment response and residual tumor activity.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"330-339"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000515142","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39580063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia. 印度尼西亚西爪哇一家三甲医院治疗的视网膜母细胞瘤的高危组织病理学特征。
IF 0.9 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-07-20 DOI: 10.1159/000517100
Nur Melani Sari, Regina Hadiputri, Maya Sari Kuntorini, Hasrayati Agustina, Friska Mardianty

Purpose: To evaluate the histopathological characteristics of clinically advanced retinoblastoma (RB) and its relationship with tumor differentiation.

Methods: This was a cross-sectional study of primary enucleated group D/E intraocular RB using medical records from 2017 to 2020 in a tertiary referral hospital. Cases with incomplete histopathological results were excluded. Tumors were classified into well, moderately, and poorly differentiated and undifferentiated. High-risk histopathological features were classified as per Thaung and Karaa [Community Eye Health. 2018;31(101):17-3].

Results: This study included 121 patients (129 eyes), of which 32.2% were diagnosed at 25-36 months. High-risk features (HRFs) were found in 100/129 eyes, and of 73 complete histopathological results, the 2 most common HRFs were postlaminar optic nerve invasion and massive choroidal invasion. RB was poorly differentiated in 69.9% and well differentiated in 12.3% of eyes. There was no statistically significant association between any HRFs and tumor differentiation, with age >2 years associated with tumor differentiation (p < 0.05).

Conclusion: The frequency of HRFs is 77.5% of primary enucleated eyes, mainly poorly and undifferentiated cells, particularly in children aged >2 years old.

目的:评估临床晚期视网膜母细胞瘤(RB)的组织病理学特征及其与肿瘤分化的关系:这是一项横断面研究,利用一家三级转诊医院2017年至2020年的病历,对原发性去核D/E组眼内RB进行研究。排除组织病理学结果不完整的病例。肿瘤被分为良好分化、中度分化、差分化和未分化。高风险组织病理学特征按照Thaung和Karaa[Community Eye Health.2018;31(101):17-3]进行分类:本研究共纳入121名患者(129只眼),其中32.2%的患者在25-36个月时确诊。在100/129只眼睛中发现了高危特征(HRFs),在73个完整的组织病理学结果中,2个最常见的HRFs是板层后视神经侵犯和大量脉络膜侵犯。69.9%的RB分化不良,12.3%的RB分化良好。任何HRFs与肿瘤分化之间均无统计学意义,年龄大于2岁与肿瘤分化有关(P < 0.05):结论:在原发性去核眼球中,HRFs的发生率为77.5%,主要是低分化和未分化细胞,尤其是在年龄大于2岁的儿童中。
{"title":"High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia.","authors":"Nur Melani Sari, Regina Hadiputri, Maya Sari Kuntorini, Hasrayati Agustina, Friska Mardianty","doi":"10.1159/000517100","DOIUrl":"10.1159/000517100","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the histopathological characteristics of clinically advanced retinoblastoma (RB) and its relationship with tumor differentiation.</p><p><strong>Methods: </strong>This was a cross-sectional study of primary enucleated group D/E intraocular RB using medical records from 2017 to 2020 in a tertiary referral hospital. Cases with incomplete histopathological results were excluded. Tumors were classified into well, moderately, and poorly differentiated and undifferentiated. High-risk histopathological features were classified as per Thaung and Karaa [<i>Community Eye Health</i>. 2018;31(101):17-3].</p><p><strong>Results: </strong>This study included 121 patients (129 eyes), of which 32.2% were diagnosed at 25-36 months. High-risk features (HRFs) were found in 100/129 eyes, and of 73 complete histopathological results, the 2 most common HRFs were postlaminar optic nerve invasion and massive choroidal invasion. RB was poorly differentiated in 69.9% and well differentiated in 12.3% of eyes. There was no statistically significant association between any HRFs and tumor differentiation, with age >2 years associated with tumor differentiation (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>The frequency of HRFs is 77.5% of primary enucleated eyes, mainly poorly and undifferentiated cells, particularly in children aged >2 years old.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"353-360"},"PeriodicalIF":0.9,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531833/pdf/oop-0007-0353.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39580066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Guarded Needle Trans-Scleral Biopsy for Uveal Melanoma: A Pilot Study. 新型防护针经巩膜活检用于葡萄膜黑色素瘤:一项初步研究。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-06-02 DOI: 10.1159/000512359
Abtin Shahlaee, Musa Abdelaziz, Michael I Seider

Introduction: Trans-scleral biopsy of uveal melanoma (UM) poses an inherent risk of tumor and possibly retinal perforation. We describe a novel technique for trans-scleral biopsy of UM and evaluate its safety and efficacy in an initial cohort of patients.

Methods: A retrospective, consecutive observational case series was conducted from October 14, 2019, to April 15, 2020, at Kaiser Permanente, San Francisco, CA among patients with UM of the ciliary body or anterior choroid undergoing trans-scleral fine-needle aspiration biopsy using a novel guarded needle technique.

Results: A total of 6 patients were included in the study, with a mean age of 64.3 (range 35-77) years (5 women 83%). Mean (±SD) tumor thickness and maximal basal diameter were 6.4 (±2.66) and 11.9 (±2.13) mm, respectively. Five out of 6 patients achieved a successful biopsy with reliable gene expression profiling (GEP) results. The only failure to obtain specimen occurred in the first attempted patient and, after a minor technique modification, all subsequent biopsies were successful. No intraoperative or short-term postoperative complications were observed in any patient.

Conclusion: This novel trans-scleral biopsy technique appears to be safe and effective when obtaining UM tissue for GEP. This method may provide a more controlled biopsy depth thereby minimizing the risk of tumor perforation and its associated complications while still obtaining adequate biopsy yield.

简介:葡萄膜黑色素瘤(UM)的经巩膜活检具有肿瘤和可能的视网膜穿孔的固有风险。我们描述了一种经巩膜活检的新技术,并在最初的患者队列中评估了其安全性和有效性。方法:2019年10月14日至2020年4月15日,在加利福尼亚州旧金山的Kaiser Permanente医院,对纤毛体或前脉络膜UM患者进行回顾性、连续观察性病例系列研究,这些患者采用新型防护针技术进行经巩膜细针穿刺活检。结果:共纳入6例患者,平均年龄64.3岁(35-77岁),其中5例女性83%。平均(±SD)肿瘤厚度为6.4(±2.66)mm,最大基底直径为11.9(±2.13)mm。6例患者中有5例获得了可靠的基因表达谱(GEP)结果的成功活检。唯一未能获得标本发生在第一个尝试的病人,经过轻微的技术修改,所有后续的活检都是成功的。所有患者均未出现术中或术后短期并发症。结论:这种新的经巩膜活检技术在获得用于GEP的UM组织时是安全有效的。这种方法可以提供一个更可控的活检深度,从而最大限度地减少肿瘤穿孔及其相关并发症的风险,同时仍然获得足够的活检产量。
{"title":"Novel Guarded Needle Trans-Scleral Biopsy for Uveal Melanoma: A Pilot Study.","authors":"Abtin Shahlaee,&nbsp;Musa Abdelaziz,&nbsp;Michael I Seider","doi":"10.1159/000512359","DOIUrl":"https://doi.org/10.1159/000512359","url":null,"abstract":"<p><strong>Introduction: </strong>Trans-scleral biopsy of uveal melanoma (UM) poses an inherent risk of tumor and possibly retinal perforation. We describe a novel technique for trans-scleral biopsy of UM and evaluate its safety and efficacy in an initial cohort of patients.</p><p><strong>Methods: </strong>A retrospective, consecutive observational case series was conducted from October 14, 2019, to April 15, 2020, at Kaiser Permanente, San Francisco, CA among patients with UM of the ciliary body or anterior choroid undergoing trans-scleral fine-needle aspiration biopsy using a novel guarded needle technique.</p><p><strong>Results: </strong>A total of 6 patients were included in the study, with a mean age of 64.3 (range 35-77) years (5 women 83%). Mean (±SD) tumor thickness and maximal basal diameter were 6.4 (±2.66) and 11.9 (±2.13) mm, respectively. Five out of 6 patients achieved a successful biopsy with reliable gene expression profiling (GEP) results. The only failure to obtain specimen occurred in the first attempted patient and, after a minor technique modification, all subsequent biopsies were successful. No intraoperative or short-term postoperative complications were observed in any patient.</p><p><strong>Conclusion: </strong>This novel trans-scleral biopsy technique appears to be safe and effective when obtaining UM tissue for GEP. This method may provide a more controlled biopsy depth thereby minimizing the risk of tumor perforation and its associated complications while still obtaining adequate biopsy yield.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"326-329"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000512359","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39580062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatal Air Embolism after Choroidal Melanoma Endoresection without Air Infusion: A Case Report. 脉络膜黑色素瘤内切术后无空气输注致死性空气栓塞1例报告。
IF 1 Q4 OPHTHALMOLOGY Pub Date : 2021-10-01 Epub Date: 2021-08-13 DOI: 10.1159/000518976
Duangnate Rojanaporn, Boontip Tipsuriyaporn, Patnarin Chulalaksiriboon, Tanit Virankabutra, Sunthiti Morakul, Bertil Damato

Background: The aim of this study was to report 2 cases of pulmonary air embolism developing several hours after choroidal melanoma endoresection without the use of air infusion during the surgery, with fatality in 1 patient.

Methods: The method of this study was case report.

Participants: Two patients with large choroidal melanomas who collapsed several hours after endoresection without air infusion as a result of pulmonary air embolism.

Results: A 72-year-old man collapsed 4 h and 30 min after endoresection without air infusion. Computerized tomography angiography confirmed air embolism. The patient died after 86 min of cardiopulmonary resuscitation. A 41-year-old woman collapsed 5 h and 30 min after endoresection, performed without air infusion and with close monitoring, which included right internal jugular vein catheterization intraoperatively. Transthoracic and transesophageal echography, performed preoperatively, intraoperatively, and postoperatively, revealed air embolism only after collapse occurred. Imaging showed the embolism to be biventricular because of patent foramen ovale. The patient was treated promptly with extracorporeal membrane oxygenation and mechanical ventilation, which resulted in a full recovery.

Conclusions: Air embolism can develop after endoresection for choroidal melanoma, despite avoiding air infusion. Further studies are needed to understand how this occurs. Special measures are indicated to detect this complication and to treat it promptly and effectively.

背景:本研究的目的是报告2例在脉络膜黑色素瘤内切术后数小时内发生肺空气栓塞,术中未使用空气输注,1例死亡。方法:采用病例报告法。参与者:两例大脉络膜黑素瘤患者,由于肺空气栓塞,在没有空气输注的情况下内镜切除数小时后塌陷。结果:1例72岁男性患者在内镜切除后4 h 30 min无空气输注后突然晕倒。计算机断层血管造影证实空气栓塞。患者经心肺复苏86分钟后死亡。1例41岁女性患者在内镜切除5 h 30 min后昏迷,术中无空气输注,严密监护,包括右颈内静脉置管。术前、术中及术后经胸、经食管超声检查显示,只有在发生虚脱后才有空气栓塞。影像学显示因卵圆孔未闭导致的栓塞为双心室栓塞。患者及时接受体外膜氧合和机械通气治疗,最终完全康复。结论:脉络膜黑色素瘤切除术后,尽管避免空气输注,仍可发生空气栓塞。需要进一步的研究来了解这是如何发生的。指出了特殊的措施,以发现这一并发症,并及时有效地治疗。
{"title":"Fatal Air Embolism after Choroidal Melanoma Endoresection without Air Infusion: A Case Report.","authors":"Duangnate Rojanaporn,&nbsp;Boontip Tipsuriyaporn,&nbsp;Patnarin Chulalaksiriboon,&nbsp;Tanit Virankabutra,&nbsp;Sunthiti Morakul,&nbsp;Bertil Damato","doi":"10.1159/000518976","DOIUrl":"https://doi.org/10.1159/000518976","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to report 2 cases of pulmonary air embolism developing several hours after choroidal melanoma endoresection without the use of air infusion during the surgery, with fatality in 1 patient.</p><p><strong>Methods: </strong>The method of this study was case report.</p><p><strong>Participants: </strong>Two patients with large choroidal melanomas who collapsed several hours after endoresection without air infusion as a result of pulmonary air embolism.</p><p><strong>Results: </strong>A 72-year-old man collapsed 4 h and 30 min after endoresection without air infusion. Computerized tomography angiography confirmed air embolism. The patient died after 86 min of cardiopulmonary resuscitation. A 41-year-old woman collapsed 5 h and 30 min after endoresection, performed without air infusion and with close monitoring, which included right internal jugular vein catheterization intraoperatively. Transthoracic and transesophageal echography, performed preoperatively, intraoperatively, and postoperatively, revealed air embolism only after collapse occurred. Imaging showed the embolism to be biventricular because of patent foramen ovale. The patient was treated promptly with extracorporeal membrane oxygenation and mechanical ventilation, which resulted in a full recovery.</p><p><strong>Conclusions: </strong>Air embolism can develop after endoresection for choroidal melanoma, despite avoiding air infusion. Further studies are needed to understand how this occurs. Special measures are indicated to detect this complication and to treat it promptly and effectively.</p>","PeriodicalId":19434,"journal":{"name":"Ocular Oncology and Pathology","volume":"7 5","pages":"321-325"},"PeriodicalIF":1.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531826/pdf/oop-0007-0321.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39684540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Ocular Oncology and Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1